Loading...
Back to narrative

Update shared on04 Sep 2025

AnalystConsensusTarget's Fair Value
CA$162.36
7.2% undervalued intrinsic discount
04 Sep
CA$150.64
Loading
1Y
40.0%
7D
-0.4%

As both Stantec’s discount rate and net profit margin remained steady, there was no change in the consensus analyst price target, which is unchanged at CA$162.36.


What's in the News


  • Stantec raised its full-year 2025 net revenue growth guidance to 10%–12%, up from prior guidance of 7%–10%.
  • The company has not repurchased any shares under its current buyback program.
  • Stantec formalized a strategic partnership with FuelPositive to support certification and regulatory approvals for decentralized, green ammonia systems in Manitoba, playing a key role in technical validation and environmental compliance.

Valuation Changes


Summary of Valuation Changes for Stantec

  • The Consensus Analyst Price Target remained effectively unchanged, at CA$162.36.
  • The Discount Rate for Stantec remained effectively unchanged, at 7.49%.
  • The Net Profit Margin for Stantec remained effectively unchanged, at 9.60%.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.